Lion Point Capital, LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$22,045,000
-21.1%
1,160,307
+38.3%
5.91%
+12.9%
Q3 2021$27,926,000
+18.2%
839,128
+37.8%
5.24%
+28.2%
Q2 2021$23,628,000
-19.5%
609,1280.0%4.08%
-23.6%
Q1 2021$29,359,000
-57.5%
609,128
-54.1%
5.34%
-59.8%
Q4 2020$69,068,000
+94.4%
1,327,7340.0%13.30%
+70.7%
Q3 2020$35,530,000
+103.2%
1,327,734
+47.9%
7.79%
+83.7%
Q2 2020$17,489,000897,7994.24%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders